Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses.

Autor: Xie, Y1, Chen, Y2, Ahmed, K A2, Li, W2, Ahmed, S2, Sami, A2, Chibbar, R3, Tang, X4, Tao, M5, Xu, J6, Xiang, J2
Zdroj: Cancer Gene Therapy. Oct2013, Vol. 20 Issue 10, p590-598. 9p. 2 Color Photographs, 1 Diagram, 2 Graphs.
Databáze: Academic Search Ultimate